Cymbalta vs Wellbutrin: Choosing for Pain, Energy, or Both

Cymbalta vs Wellbutrin is usually settled less by which drug is stronger for depression than by everything else you’re carrying: the back pain that never lets up, the exhaustion that makes mornings feel impossible, or the worry humming underneath it all.

Your brain runs on chemical messengers that do different jobs. The Cymbalta prescribing information links duloxetine’s effects on mood, anxiety, and pain to boosting serotonin and norepinephrine activity in the central nervous system. The Wellbutrin XL label describes bupropion as a relatively weak blocker of norepinephrine and dopamine reuptake that doesn’t touch serotonin reuptake at all. Matching those targets to your symptoms takes precision.

The standard advice has long been that most antidepressants work about equally well, and the evidence supports it. A 2018 Lancet meta-analysis of 522 trials and 116,477 adults found all 21 antidepressants studied beat placebo for depression, with modest differences between them. That’s a real and reassuring result.

But depression rarely arrives alone, and at Siggy we believe the choice should follow your whole symptom pattern, including the pain, fatigue, and anxiety riding alongside your mood.

That means matching each drug’s targets to the symptoms surrounding your low mood as well as the mood itself. Cymbalta and Wellbutrin sit at opposite ends of that pattern: one anchored in pain and anxiety relief, the other in energy and a lighter sexual side effect burden. Which one fits you comes down to your comorbid symptoms and the pharmacology.

What This Page Covers

• How Cymbalta and Wellbutrin Work Differently
• Which Works Better for Depression?
• When Chronic Pain Is Part of the Picture
• When Fatigue and Low Energy Lead
• When Anxiety Comes With Depression
• Side Effects Side by Side
• Can You Take Cymbalta and Wellbutrin Together?
• Who Each Medication May Fit
• How Siggy Thinks About Matching Medication to Symptoms

How Cymbalta and Wellbutrin Work Differently

Cymbalta (duloxetine) is a serotonin and norepinephrine reuptake inhibitor, or SNRI. It is FDA-approved for major depression, generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. For depression, the label’s recommended dose is 40 to 60 mg a day, and it notes there’s no evidence that going above 60 mg adds benefit.

Wellbutrin XL (bupropion) is an aminoketone antidepressant approved for major depression and for preventing seasonal depression. It usually starts at 150 mg each morning and can rise to 300 mg after four days. It isn’t a controlled substance, and a sustained-release form of bupropion is approved to help people quit smoking.

Because bupropion skips serotonin, its side effect profile looks very different from Cymbalta’s. That difference, more than raw antidepressant strength, is what this comparison really turns on.

Which Works Better for Depression?

The honest answer is that neither has a proven edge. The only direct comparison is a small randomized trial of 49 people whose depression hadn’t improved on two SSRIs. They were assigned to duloxetine 120 mg or bupropion XL 300 mg for six weeks, and 60% to 70% responded, with roughly 30% to 40% in remission and no significant difference between groups. The study was single-blind, had no placebo arm, and was small.

Tolerability may matter more than efficacy. In that 2018 Lancet meta-analysis, duloxetine was among the antidepressants with the highest dropout rates in head-to-head trials. So the better question is which drug fits the rest of your symptoms.

When Chronic Pain Is Part of the Picture

Pain is where Cymbalta clearly separates. Its FDA approvals include three pain conditions, while Wellbutrin has none.

The strongest summary comes from a 2023 Cochrane review of 176 trials with 28,664 adults. Across 25 antidepressants, duloxetine was the only one the authors were confident works for chronic pain, with small to moderate benefits at the standard 60 mg dose. Evidence for every other antidepressant, other than a promising signal for milnacipran, was low certainty.

There’s a catch. Most of those trials excluded people with depression, so the review couldn’t say how well duloxetine treats pain and depression together. In practice, pain and mood often move on different clocks, which our guide to how long Cymbalta takes to work walks through week by week.

When Fatigue and Low Energy Lead

If exhaustion, oversleeping, or feeling slowed down is front and center, bupropion has the better track record. In a six-trial pooled analysis comparing bupropion with SSRIs, bupropion improved sleepiness and fatigue more. Among people who reached remission, residual fatigue affected 19.5% on bupropion versus 30.2% on SSRIs. The comparison was with SSRIs, not duloxetine, so it points in a direction rather than settling the matchup.

Cymbalta can tip sleep either way. In the label’s pooled trials, sleepiness affected 10% of people on duloxetine versus 3% on placebo, fatigue 9% versus 5%, and insomnia 9% versus 5%. That isn’t the whole story, though. A duloxetine energy analysis of 10 placebo-controlled trials found low-energy symptoms improved more on duloxetine than placebo starting in week 1.

Bupropion’s energy comes with a trade-off at night. Insomnia affected 11% of people on 300 mg of sustained-release bupropion versus 6% on placebo, and the label directs that Wellbutrin XL be taken in the morning. For more on when prescribers reach for bupropion, see when doctors choose Wellbutrin over an SSRI.

When Anxiety Comes With Depression

Cymbalta is FDA-approved for generalized anxiety disorder. Wellbutrin isn’t approved for any anxiety disorder, and anxiety (5% vs 3%) and agitation (3% vs 2%) were more common than with placebo in its 300 mg trials.

Serotonin seems to matter here. In an anxious depression analysis of 1,275 patients with high anxiety, response rates were 65.4% with SSRIs versus 59.4% with bupropion, though Cymbalta itself wasn’t studied. About 17 people would need an SSRI instead of bupropion for one extra responder, and the authors read the result as preliminary evidence that serotonin plays a central role in anxiety. With lower anxiety levels, there was no difference.

Side Effects Side by Side

Both labels flag blood pressure, but most other side effects point in opposite directions.

Feature	Cymbalta	Wellbutrin
Common early effect	Nausea	Dry mouth, insomnia
Sexual side effects	Above placebo	Similar to placebo
Weight over time	Small gain	Small loss
Sleep	Sleepiness or insomnia	Insomnia
Blood pressure	Check before and during	Check before and during
Key safety caution	Liver injury, heavy alcohol	Dose-related seizures

Nausea affected 23% of people on Cymbalta versus 8% on placebo, while dry mouth affected 17% on 300 mg of bupropion versus 7% on placebo. A sexual dysfunction meta-analysis found duloxetine caused significantly more sexual dysfunction than placebo, while bupropion did not differ from placebo. Cymbalta’s label reports erectile dysfunction in 4% versus 1%.

Weight differences are real but small. In a duloxetine weight analysis of 10 registration trials, people lost about 0.5 kg over the first two months versus a 0.2 kg gain on placebo, while a year-long open-label study found a mean gain of 1.1 kg. A 2024 weight-change study of 183,118 patients found that, compared with sertraline, duloxetine was linked to 0.34 kg more gain at six months and bupropion to 0.22 kg less, with a 15% lower risk of gaining at least 5% of body weight. See our guide to Wellbutrin and weight for more.

The serious cautions differ too. Bupropion’s seizure risk is dose-related, about 0.1% at up to 300 mg of the sustained-release form, and it’s off the table for people with a seizure disorder, bulimia or anorexia, or abrupt withdrawal from alcohol, benzodiazepines, barbiturates, or seizure medicines. Duloxetine carries a liver injury warning, so the label says not to prescribe it with substantial alcohol use or chronic liver disease. Both carry a boxed warning about suicidal thoughts in children, teens, and young adults. If you have thoughts of suicide, call or text 988, or call 911 if you’re in immediate danger.

Can You Take Cymbalta and Wellbutrin Together?

They can be combined, and the pairing has been studied, but it needs care. The Wellbutrin label says bupropion and its metabolites inhibit CYP2D6, and the Cymbalta label notes that potent CYP2D6 inhibitors raise duloxetine levels by about 60% on average. The Wellbutrin label also urges extreme caution with other drugs that lower the seizure threshold, including antidepressants.

The evidence for the combination is thin. In a 46-patient combination trial of treatment-resistant depression with atypical features, 26.1% responded when bupropion was added to duloxetine versus 21.7% with placebo added, and the authors said more research is needed before drawing firm conclusions.

Who Each Medication May Fit

Cymbalta may fit when depression comes with chronic pain, such as nerve pain, fibromyalgia, or back and joint pain, or with generalized anxiety. It may be a poorer fit if you drink heavily, have liver disease or severe kidney disease, or if sexual side effects would be hard to live with.

Wellbutrin may fit when fatigue, oversleeping, or low motivation leads, when SSRI sexual side effects or weight gain were a problem before, or when quitting smoking is also a goal. It may be a poorer fit with a seizure history, an eating disorder, prominent anxiety, or stubborn insomnia.

Before starting either, a prescriber will usually check your blood pressure, review your medications for interactions, and screen for bipolar disorder, which both labels require. For how these compare with serotonin-only options, see our SNRI vs SSRI comparison.

How Siggy Thinks About Matching Medication to Symptoms

“When side effects start, you’re on your own until the next appointment.” That gap shows up in the numbers: in the 2024 study, six-month adherence was just 28% for duloxetine and 41% for bupropion.

Siggy’s care currently centers on SSRI-based treatment for anxiety and depression, so Siggy doesn’t prescribe or manage Cymbalta or Wellbutrin. What carries over is the principle behind this comparison: your sleep, energy, pain, and side effects are part of one pattern and should shape the plan together. Our guide to how SSRI medications compare applies the same thinking to the medications Siggy’s prescribers work with.

Cymbalta leans toward pain and anxiety, while Wellbutrin leans toward energy and fewer sexual side effects. If anxiety or depression is what you’re dealing with, Siggy’s free, anonymous intake takes no name, email, or login, and you get a consult summary and a downloadable report you can share with any clinician.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.